Literature DB >> 29152909

History of the worldwide emergence of Kawasaki disease.

Jane C Burns1.   

Abstract

Dr. Kawasaki saw his first case of the disease that would come to bear his name in 1961. His meticulous description of the clinical syndrome persists as the case definition to the present day. This review chronicles the emergence and recognition of Kawasaki disease in Asia and Western countries and articulates the old disease/new disease controversy.
© 2017 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  Kawasaki disease; coronary artery aneurysm; history

Mesh：

Year:  2017        PMID： 29152909     DOI： 10.1111/1756-185X.13214

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN： 1756-1841            Impact factor:   2.454


  7 in total

1.  Evaluation of Kawasaki's disease-associated coronary artery aneurysms with 3D CT cinematic rendering.

Authors:  Steven P Rowe; Stefan L Zimmerman; Pamela T Johnson; Elliot K Fishman
Journal:  Emerg Radiol       Date:  2018-02-27

Review 2.  Kawasaki Disease in the neonate: case report and literature review.

Authors:  Fajer Altammar; Bianca Lang
Journal:  Pediatr Rheumatol Online J       Date:  2018-07-03       Impact factor: 3.054

3.  Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children.

Authors:  Men-Ren Chen; Ho-Chang Kuo; Yann-Jinn Lee; Hsin Chi; Sung Chou Li; Hung-Chang Lee; Kuender D Yang
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

Review 4.  Global epidemiology of vasculitis.

Authors:  Richard A Watts; Gulen Hatemi; Jane C Burns; Aladdin J Mohammad
Journal:  Nat Rev Rheumatol       Date:  2021-12-01       Impact factor: 20.543

Review 5.  Kawasaki Disease and Coronary Artery Involvement: A Narrative Review.

Authors:  Kruthiga Rajasekaran; Shrimahitha Duraiyarasan; Mayowa Adefuye; Nisha Manjunatha; Vinutna Ganduri
Journal:  Cureus       Date:  2022-08-24

6.  Observation on the clinical effect of high-dose Intravenous Immunoglobulin combined with low-dose prednisone acetate in the treatment of patients with Kawasaki Disease.

Authors:  Hao Zhang; Mei-Ying Wang; Yong-Nan Teng; Xiao-Dan Wang; Hai-Tao Cao
Journal:  Pak J Med Sci       Date:  2021 Jul-Aug       Impact factor: 1.088

7.  FNDC1 Polymorphism (rs3003174 C > T) Increased the Incidence of Coronary Artery Aneurysm in Patients with Kawasaki Disease in a Southern Chinese Population.

Authors:  Kun Lin; Linyuan Zhang; Yishuai Wang; Jinqing Li; Yufen Xu; Di Che; Hanran Mai; Hongyan Yu; Lanyan Fu; Bing Wei; Zhiyong Jiang; Lei Pi; Xiaoqiong Gu
Journal:  J Inflamm Res       Date:  2021-06-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.